This property was exploited by the company MGI Pharma to develop an illudin-derivative called Irofulven for use as an anti-cancer medicine.
•
It is thought responsible for the ill effects caused by various Omphalotus species like O. olearius and O. illudens (jack o'lantern mushrooms), and O. nidiformis (Australian ghost fungus).